Opposite associations between alanine aminotransferase and gamma-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

Kathryn H Williams; David R Sullivan; Geoffrey C Nicholson; Jacob George; Alicia J Jenkins; Andrzej S Januszewski; Val J Gebski; Patrick Manning; Yong Mong Tan; Mark W Donoghoe; Christian Ehnholm; Simon Young; Richard O'Brien; Luke Buizen; Stephen M Twigg; Anthony C Keech

Journal article

Opposite associations between alanine aminotransferase and gamma-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

Kathryn H Williams, David R Sullivan, Geoffrey C Nicholson, Jacob George, Alicia J Jenkins, Andrzej S Januszewski, Val J Gebski, Patrick Manning, Yong Mong Tan, Mark W Donoghoe, Christian Ehnholm, Simon Young, Richard O'Brien, Luke Buizen, Stephen M Twigg, Anthony C Keech

Metabolism | W B SAUNDERS CO-ELSEVIER INC | Published : 2016

DOI: 10.1016/j.metabol.2015.12.008

University of Melbourne Researchers

Richard O'Brien Author Medical Education

Grants

Awarded by NHMRC

Funding Acknowledgements

KHW was the recipient of a National Health and Medical Research Council (NHMRC) Medical and Dental Research Scholarship. Work conducted by KHW has also been supported by the Australian branch of the Thessalian Society and the Diabetes Research Foundation, University of Sydney. The study was partly supported by funding from the NHMRC to the NHMRC Clinical Trials Centre (Program Grant 1037786). The FIELD study was funded by Fournier Laboratories (now Abbott).